Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36

Nature volume 504, pages 172–176 (2013)Cite this article

Subjects

Abstract

Members of the CD36 superfamily of scavenger receptor proteins are important regulators of lipid metabolism and innate immunity. They recognize normal and modified lipoproteins, as well as pathogen-associated molecular patterns. The family consists of three members: SR-BI (which delivers cholesterol to the liver and steroidogenic organs and is a co-receptor for hepatitis C virus), LIMP-2/LGP85 (which mediates lysosomal delivery of β-glucocerebrosidase and serves as a receptor for enterovirus 71 and coxsackieviruses) and CD36 (a fatty-acid transporter and receptor for phagocytosis of effete cells and Plasmodium-infected erythrocytes). Notably, CD36 is also a receptor for modified lipoproteins and β-amyloid, and has been implicated in the pathogenesis of atherosclerosis and of Alzheimer’s disease1. Despite their prominent roles in health and disease, understanding the function and abnormalities of the CD36 family members has been hampered by the paucity of information about their structure. Here we determine the crystal structure of LIMP-2 and infer, by homology modelling, the structure of SR-BI and CD36. LIMP-2 shows a helical bundle where β-glucocerebrosidase binds, and where ligands are most likely to bind to SR-BI and CD36. Remarkably, the crystal structure also shows the existence of a large cavity that traverses the entire length of the molecule. Mutagenesis of SR-BI indicates that the cavity serves as a tunnel through which cholesterol(esters) are delivered from the bound lipoprotein to the outer leaflet of the plasma membrane. We provide evidence supporting a model2 whereby lipidic constituents of the ligands attached to the receptor surface are handed off to the membrane through the tunnel, accounting for the selective lipid transfer characteristic of SR-BI and CD36.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Structure of the human LIMP-2 luminal domain.
Figure 2: The helical bundle face and the apex region of LIMP-2 are required for association with β-GCase.
Figure 3: SR-BI and CD36 use the same interface as LIMP-2 for ligand binding.
Figure 4: SR-BI has a functionally important tunnel.

Similar content being viewed by others

Accession codes

Accessions

Protein Data Bank

Data deposits

Atomic coordinates and structure factors have been deposited in Protein Data Bank under accession number 4F7B.

References

  1. Canton, J., Neculai, D. & Grinstein, S. Scavenger receptors in homeostasis and immunity. Nature Rev. Immunol. 13, 621–634 (2013)

    Article  CAS  Google Scholar 

  2. Rodrigueza, W. V. et al. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J. Biol. Chem. 274, 20344–20350 (1999)

    Article  CAS  Google Scholar 

  3. Yu, M. et al. Exoplasmic cysteine Cys384 of the HDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity. Proc. Natl Acad. Sci. USA 108, 12243–12248 (2011)

    Article  ADS  CAS  Google Scholar 

  4. Rasmussen, J. T., Berglund, L., Rasmussen, M. S. & Petersen, T. E. Assignment of disulfide bridges in bovine CD36. Eur. J. Biochem. 257, 488–494 (1998)

    Article  CAS  Google Scholar 

  5. Reczek, D. et al. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of β-glucocerebrosidase. Cell 131, 770–783 (2007)

    Article  CAS  Google Scholar 

  6. Blanz, J. et al. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand β-glucocerebrosidase. Hum. Mol. Genet. 19, 563–572 (2010)

    Article  CAS  Google Scholar 

  7. Zachos, C., Blanz, J., Saftig, P. & Schwake, M. A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand β-glucocerebrosidase. Traffic 13, 1113–1123 (2012)

    Article  CAS  Google Scholar 

  8. Ryeom, S. W., Silverstein, R. L., Scotto, A. & Sparrow, J. R. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J. Biol. Chem. 271, 20536–20539 (1996)

    Article  CAS  Google Scholar 

  9. Jimenez-Dalmaroni, M. J. et al. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS ONE 4, e7411 (2009)

    Article  ADS  Google Scholar 

  10. Puente Navazo, M. D., Daviet, L., Ninio, E. & McGregor, J. L. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler. Thromb. Vasc. Biol. 16, 1033–1039 (1996)

    Article  CAS  Google Scholar 

  11. Stylianou, I. M. et al. Novel ENU-induced point mutation in scavenger receptor class B, member 1, results in liver specific loss of SCARB1 protein. PLoS ONE 4, e6521 (2009)

    Article  ADS  Google Scholar 

  12. Chadwick, A. C. & Sahoo, D. Functional characterization of newly-discovered mutations in human SR-BI. PLoS ONE 7, e45660 (2012)

    Article  ADS  CAS  Google Scholar 

  13. Kar, N. S., Ashraf, M. Z., Valiyaveettil, M. & Podrez, E. A. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36. J. Biol. Chem. 283, 8765–8771 (2008)

    Article  CAS  Google Scholar 

  14. Rigotti, A., Miettinen, H. E. & Krieger, M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 24, 357–387 (2003)

    Article  CAS  Google Scholar 

  15. Gu, X. et al. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem. 273, 26338–26348 (1998)

    Article  CAS  Google Scholar 

  16. Liu, B. & Krieger, M. Highly purified scavenger receptor class B, type I reconstituted into phosphatidylcholine/cholesterol liposomes mediates high affinity high density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 277, 34125–34135 (2002)

    Article  CAS  Google Scholar 

  17. Gu, X., Kozarsky, K. & Krieger, M. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275, 29993–30001 (2000)

    Article  CAS  Google Scholar 

  18. Ji, Y. et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272, 20982–20985 (1997)

    Article  CAS  Google Scholar 

  19. Nieland, T. J., Penman, M., Dori, L., Krieger, M. & Kirchhausen, T. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc. Natl Acad. Sci. USA 99, 15422–15427 (2002)

    Article  ADS  CAS  Google Scholar 

  20. Nieland, T. J. et al. Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity. Biochemistry 47, 460–472 (2008)

    Article  CAS  Google Scholar 

  21. Yu, M., Lau, T. Y., Carr, S. A. & Krieger, M. Contributions of a disulfide bond and a reduced cysteine side chain to the intrinsic activity of the high-density lipoprotein receptor SR-BI. Biochemistry 51, 10044–10055 (2012)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank W. Temple, D. Cossar, S. Graslund, C. Arrowsmith, R. Stahelin, L. Andresen, J. Groth, M. Langer and J. Scott for assistance and discussions. This study was supported by the Canadian Institutes for Health Research (grants MOP-102474 and MOP-126069) and the Deutsche Forschungsgemeinschaft (grants GRK1459 to M.S. and SFB877). F.Z. is supported through the Böhringer Ingelheim Fonds. W.S.T. is the recipient of a Canada Research Chair in Molecular Cell Biology. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Cell Biology Program, The Hospital for Sick Children, Toronto M5G 1X8, Canada,

    Dante Neculai, Richard F. Collins, Jonathan Plumb, William S. Trimble & Sergio Grinstein

  2. Biochemisches Institut der Christian-Albrechts-Universität zu Kiel, Otto-Hahn-Platz 9, 24118 Kiel, Germany,

    Michael Schwake, Friederike Zunke, Judith Peters & Paul Saftig

  3. Biochemie III, Fakultät für Chemie, Universität Bielefeld, Universitätstrasse 25, 33615 Bielefeld, Germany,

    Michael Schwake

  4. Structural Genomics Consortium, University of Toronto, 101 College Street, Toronto, Ontario M5G 1L7, Canada,

    Mani Ravichandran, Mirela Neculai, Peter Loppnau, Juan Carlos Pizarro, Alma Seitova & Sirano Dhe-Paganon

  5. Department of Tropical Medicine, Tulane University, New Orleans, 70118, Louisiana, USA

    Juan Carlos Pizarro

  6. Department of Biochemistry, University of Toronto, 1 King’s College Circle, Toronto, Ontario M5S 1A8, Canada,

    William S. Trimble & Sergio Grinstein

  7. Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 209 Victoria Street, Toronto M5C 1N8, Canada,

    Sergio Grinstein

  8. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, 02215, Massachusetts, USA

    Sirano Dhe-Paganon

Authors
  1. Dante Neculai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Schwake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mani Ravichandran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Friederike Zunke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard F. Collins
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Judith Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mirela Neculai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jonathan Plumb
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Peter Loppnau
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Juan Carlos Pizarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Alma Seitova
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. William S. Trimble
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Paul Saftig
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Sergio Grinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Sirano Dhe-Paganon
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.G., W.S.T., P.S., M.S., S.D.-P. and D.N. designed the research; D.N., M.R., M.N., P.L., A.S., J.C.P., R.C., J. Plumb, F.Z. and J. Peters performed the experiments; S.G., W.S.T., P.S., M.S., S.D.-P., D.N. and F.Z. analysed the results; S.G. wrote the paper; W.S.T., P.S., M.S., S.D.-P., D.N., J. Peters and F.Z. edited and commented on the manuscript.

Corresponding author

Correspondence to Sergio Grinstein.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

This file contains Supplementary Text, Supplementary Figures 1-12, Supplementary Table 1 and Additional references. (PDF 22872 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neculai, D., Schwake, M., Ravichandran, M. et al. Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36. Nature 504, 172–176 (2013). https://doi.org/10.1038/nature12684

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature12684

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing